Johnson & Johnson

NYSE: JNJ
$160.88
-$2.79 (-1.7%)
Closing Price on October 25, 2024

JNJ Articles

The three major US stock indexes opened higher this morning in advance of Fed Chairman Ben Bernanke’s semi-annual report to Congress and following some data on inflation (more coverage here),...
Health care giant Johnson & Johnson (NYSE: JNJ) reported second-quarter earnings this morning, posting adjusted earnings per share (EPS) of $1.30 on revenue of $16.5 billion. The consensus...
The three major US stock indexes opened lower this morning following some lackluster data on the US economy. The Empire State manufacturing data improved, but retail sales posted an unexpected...
Each year, 24/7 Wall St. identifies 10 important American brands that we predict will disappear within a year. This year’s list reflects the brutally competitive nature of certain industries and...
The Federal Reserve says it will increase help to the U.S. economy, and it may be willing to do more. (Reuters) Spain may request more financial aid for its troubled banks. (Reuters)...
Huntington Asset Advisors has announced the launch of an actively managed exchange-traded fund via Huntington Strategy Shares called the Huntington EcoLogical Strategy Shares ETF (HECO).  This is...
The three major US stock indexes opened lower this morning following European markets where equities also traded lower this morning. US data related to retail sales (our coverage here) and producer...
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Wednesday. Apple Inc. (NASDAQ: AAPL) Reiterated Buy with $670 target at Argus;...
Nasdaq (NASDAQ: NDAQ) will announce what compensation it will give Facebook (NASDAQ: FB) brokers. (Reuters) The European Union continues to look at ways to help the region’s damaged banks....
The 10-year Treasury hit yet another record low under 1.6% today and stocks are in the tank again due to poor economic data.  Europe continues to face a meltdown and the hope is for a rate cut out...
AuthorDendreon Corporation (NASDAQ: DNDN) is in trouble.  That is what the performance is telling investors.  The maker of Provenge as a late-stage prostate cancer treatment has three issues...
Berkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) and Warren Buffett have just released their most recent U.S.-listed equity holdings for the Berkshire Hathaway empire. This cut off date is as of March...
Coty, which had made a $10.7 billion offer to buy Avon Products (NYSE: AVP), withdrew its bid. It said the the Avon board had failed to react to its offer by a Monday deadline. Avon’s shares will...
A stock market that sells off eight of nine days is not a good market.  Even the Facebook IPO is being viewed as a one-off item rather than a systemic item which will make the market stronger. ...
Coalition talks in Greece have broken down and are not likely to resume. This means new elections are almost inevitable. That will delay the ability of the European Union and IMF to know what the...